Inventory / revenue moved 581 bp lower
Inventory / revenue changed -581 basis points from the comparable as-filed period.
55.75%→49.94%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SUPN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Selling, general & administrative decreased 28.7%
Selling, general & administrative changed -28.7% from the comparable as-filed period.
$179.7M→$128.1M2 prior comparisons
Current assets increased 19.8%
Current assets changed +19.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$593.9M→$711.2M4 prior comparisons
SBC / revenue moved 1207 bp lower
SBC / revenue changed -1207 basis points from the comparable as-filed period.
16.00%→3.94%2 prior comparisons
Working capital / assets moved 1192 bp higher
Working capital / assets changed +1192 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
18.54%→30.47%4 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed +110.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$61.8M→$6.4M2 prior comparisons
Operating income changed across a sign change
Operating income changed +135.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$60.2M→$21.2M2 prior comparisons
Current liabilities decreased 13.7%
Current liabilities changed -13.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
$330.6M→$285.4M4 prior comparisons
Capital expenditure increased 78.3%
Capital expenditure changed +78.3% from the comparable as-filed period.
$129,000→$230,0002 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +110.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$61.7M→$6.6M2 prior comparisons
Cash & equivalents increased 16.2%
Cash & equivalents changed +16.2% from the comparable as-filed period.
$151.4M→$175.9M2 prior comparisons
R&D / revenue moved 393 bp lower
R&D / revenue changed -393 basis points from the comparable as-filed period.
15.29%→11.36%2 prior comparisons
Receivables / revenue moved 554 bp higher
Receivables / revenue changed +554 basis points from the comparable as-filed period.
89.15%→94.68%2 prior comparisons
Free-cash-flow margin moved 3498 bp higher
Free-cash-flow margin changed +3498 basis points from the comparable as-filed period.
-32.17%→2.81%2 prior comparisons
Operating cash-flow margin moved 3501 bp higher
Operating cash-flow margin changed +3501 basis points from the comparable as-filed period.
-32.10%→2.91%2 prior comparisons
Research & development decreased 12.3%
Research & development changed -12.3% from the comparable as-filed period.
$29.4M→$25.8M2 prior comparisons
Total assets decreased 1.6%
Total assets changed -1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
$1.4B→$1.4B4 prior comparisons
Shares outstanding increased 1.6%
Shares outstanding changed +1.6% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
57,339,350→58,235,7167 prior comparisons
Capex / revenue moved 3 bp higher
Capex / revenue changed +3 basis points from the comparable as-filed period.
0.07%→0.10%2 prior comparisons
Inventory increased 5.7%
Inventory changed +5.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$107.1M→$113.2M4 prior comparisons
Research & development increased 33.2%
Research & development changed +33.2% from the comparable as-filed period.
$22.1M→$29.5M2 prior comparisons
Operating income changed across a sign change
Operating income changed -577.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$12.1M→-$58.0M2 prior comparisons
Current liabilities increased 21.3%
Current liabilities changed +21.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$286.4M→$347.4M4 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed -109.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$58.1M→-$5.4M3 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed -108.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$58.5M→-$4.8M3 prior comparisons
Working capital / assets moved 640 bp lower
Working capital / assets changed -640 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
32.73%→26.34%4 prior comparisons
Working capital decreased 16.9%
Working capital changed -16.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$452.5M→$376.1M4 prior comparisons
Operating cash-flow margin moved 3757 bp lower
Operating cash-flow margin changed -3757 basis points from the comparable as-filed period.
35.38%→-2.20%2 prior comparisons
Free-cash-flow margin moved 3756 bp lower
Free-cash-flow margin changed -3756 basis points from the comparable as-filed period.
35.10%→-2.46%2 prior comparisons
Receivables / revenue moved 1150 bp higher
Receivables / revenue changed +1150 basis points from the comparable as-filed period.
85.12%→96.62%2 prior comparisons
Current ratio decreased 19.3%
Current ratio changed -19.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
2.58→2.084 prior comparisons
Capital expenditure increased 24.8%
Capital expenditure changed +24.8% from the comparable as-filed period.
$455,000→$568,0003 prior comparisons
Total assets increased 3.3%
Total assets changed +3.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.4B→$1.4B4 prior comparisons
Capex / revenue moved 2 bp lower
Capex / revenue changed -2 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.28%→0.26%2 prior comparisons
Stock-based compensation increased 15.1%
Stock-based compensation changed +15.1% from the comparable as-filed period.
$7.5M→$8.6M2 prior comparisons
SBC / revenue moved 59 bp lower
SBC / revenue changed -59 basis points from the comparable as-filed period.
4.54%→3.94%2 prior comparisons
Current assets decreased 2.1%
Current assets changed -2.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$738.9M→$723.5M4 prior comparisons
R&D / revenue moved 8 bp higher
R&D / revenue changed +8 basis points from the comparable as-filed period.
13.37%→13.45%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.